Some of the largest medtech companies showed in 2017 that they are ready to grow through embrace the new healthcare ecosystem. Medical device companies are putting greater emphasis on value-based. They’re putting more attention to clinical and economic research and adopting digital products that incorporate machine learning and data integration. Questions, though, still remain as […]
The American division of Japan’s Nihon Kohden (TYO:6849) won a Pentagon contract worth more than $35.3 million, the U.S. Defense Dept. said yesterday. The 1-year deal, which has 8 1-year extension options, calls for Irvine, Calif.-based Nihon Kohden America to supply the U.S. Air Force, Army, Navy, Marine Corps and federal civilian agencies with its patient monitoring equipment, […]
Nihon Kohden (TYO:6849) said Tuesday they signed a 3-year group purchase order agreement with healthcare service company Novation. The deal positions Japan-based Nihon Kohden to provide Novation with sleep assessment and neurodiagnostic services and equipment. The contract became effective July 1st, according to the companies. “We are honored to be a partner with Novation, as our […]
The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.
The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.
Updated March 7, 2012, at 1:30 p.m. with comments from GE Healthcare.
MASSDEVICE ON CALL — GE Healthcare (NYSE: GE) announced another round of layoffs at its South Burlington, Vt., facility, a move it said is a result of declining demand for health care IT and performance solutions businesses.
The move is the "subsequent action" of layoffs numbering around 50 workers at the same facility last month, GE spokesman Corey Miller told MassDevice.
Edwards Lifesciences (NYSE:EW) said it will re-state its financial results for the first 3 quarters of 2011, “due to certain technical errors in the balance sheets and cash flow statements for these interim periods.”
The Irvine, Calif.-based heart valve maker said the errors involve the mis-statement of short-term investments as cash & equivalents, plus the way it treated tax benefits from stock plans.